Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
32.58
+0.13 (0.40%)
At close: Oct 21, 2026, 4:00 PM EDT
32.58
0.00 (0.00%)
After-hours: Oct 21, 2026, 7:30 PM EDT
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year. That makes Maze Therapeutics the 29,276th largest employer in the world and 3,713th in the United States.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$947,447
Market Cap
1.81B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 300 |
| Biohaven | 274 |
| Xencor | 260 |
| Zenas BioPharma | 167 |
| Absci | 140 |
| Mesoblast | 108 |
MAZE News
- 2 days ago - Maze Therapeutics initiated with a Buy at Canaccord - TheFly
- 15 days ago - Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026 - GlobeNewsWire
- 4 weeks ago - Maze Therapeutics initiated with a Buy at Citi - TheFly
- 4 weeks ago - Vertex's Kidney Drug Success Sparks a 22% Surge for This Rival Biotech - Barrons
- 5 weeks ago - Maze Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - Maze Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 6 weeks ago - Maze Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 7 weeks ago - Maze Therapeutics to Participate in Three Upcoming Investor Conferences - GlobeNewsWire